CCR Milestones: Annual Highlights 2024

This issue of Milestones highlights some of our scientific advances in FY 2023-2024.

Major prognostic and treatment advances are made against a rare and deadly disease.

Studying osteosarcoma in dogs may improve treatment options for people and pets.

A new view of cell division changes the way we think about how some cancer drugs impact cells.

A 30-year trial leads to a highly effective treatment.

Can a survival mechanism used by bacteria create a better drug delivery system?

Studies identify a marker of treatment response for patients with advanced, drug-resistant ovarian cancer. 

An immune signal that reprograms fat metabolism could help control nonalcoholic fatty liver disease. 

NCI trial leads to first drug approval for a very rare cancer.  

Where and how fast a protein is made in the cell affects what it does. 

An understudied immune cell can exhibit potent anti-tumor activity against liver cancer.

New faculty join CCR each year to contribute to our work of making breakthrough scientific discoveries to find cures and treatments for cancer. We also recognize current faculty who have started new roles within CCR.

We are proud of our CCR awardees who represent a spectacular array of accomplishments.

Take a look at our year as told by the numbers to see a snapshot of the breakthrough scientific discoveries and important work happening at CCR.